OCGN — Ocugen, Inc. stock price, charts and financials

QT20Ocugen, Inc.

Ocugen, Inc. (NASDAQ: OCGN) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
1.31
+0.06+4.80%
OverviewShort InterestFilings
OCGNQT20Ocugen, Inc.·NASDAQ
1.31+4.80%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 30, 2026DEF 14ADefinitive proxy statement
Jul 30, 2026DEFA14AAdditional proxy soliciting materials
Jul 29, 2026SC 13GBeneficial ownership statement (passive)
Jul 20, 2026PRE 14APreliminary proxy statement
Jul 13, 20268-KCurrent report
Jun 17, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 11, 20268-KCurrent report
Jun 03, 20268-KCurrent report
May 14, 20268-KCurrent report
May 14, 20268-KCurrent report
May 08, 202610-QQuarterly report
May 07, 20268-KCurrent report
May 05, 20268-KCurrent report
May 04, 20268-KCurrent report
Apr 28, 2026DEFA14AAdditional proxy soliciting materials
Apr 28, 2026ARSAnnual report to shareholders
Apr 28, 2026DEF 14ADefinitive proxy statement
Apr 20, 2026PRER14APRER14A
Apr 17, 2026PRE 14APreliminary proxy statement
Apr 14, 2026SC 13GBeneficial ownership statement (passive)
#1 / 25 of 368
Page
▼
/ 15